Fortress Biotech, Inc. (NASDAQ: FBIO) is not putting all its eggs in one basket. This is a biopharmaceutical company with multiple revenue streams and a profuse product portfolio so diversified that Harry Markowitz, the father of modern portfolio theory, might tip his hat to the way the company has sought to mitigate developmental risks. Fortress’ […]

Before the opening bell, Agora Holdings, Inc. (OTC: AGHI) issued an update on its FRAME social media management technology, providing some additional insight into how the platform can be used to streamline personal branding efforts for both individuals and businesses. The news release highlights the importance of establishing and maintaining a presence on social media […]

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharma company that focuses on the development of innovative treatments for chronic kidney disease-related anemia, is maintaining its ‘Buy’ rating, with a recommended stock price target of $18 compared to the current $8.90, according to an Aegis Capital Corp. report (http://dtn.fm/2z8XE) released on November 15. The rating and suggested […]

In its latest quarterly report (10-Q), National Waste Management Holdings (OTC: NWMH), a solid waste management company headquartered in central Florida, demonstrated impressive growth. The company is currently running at full speed to achieve its stated objective of becoming a leading national solid waste company through organic growth and acquisitions. Revenues for the third quarter […]

Citius Pharmaceuticals, Inc. (OTCQB: CTXR), a specialty biopharmaceutical company that develops and commercializes therapeutics products, has been a topic of conversation among analysts since the initiation of its phase III clinical trial of Mino-Lok™, an antibiotic lock solution used to salvage infected central venous catheters and treat bloodstream infections that stem from catheters. This phase […]

The human imagination is capable of incredibly brilliant creations, including the technological innovations that Agora Holdings, Inc. (OTC: AGHI) is developing to create tools that can help people and companies save time and improve performance, all while publishing more content. Agora Holdings, together with subsidiary Geegle Media and its affiliates, is a global family entertainment […]

Zogenix, Inc (NASDAQ: ZGNX) is a clinical stage pharmaceutical company committed to the development and commercialization of therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases. The company’s lead product candidate, ZX008, is currently being evaluated for the treatment of one such disease – Dravet Syndrome. Despite […]

Matinas BioPharma Holdings, Inc. (OTCQB: MTNB), is a biopharmaceutical company still in its clinical stages, focused on identifying and developing treatments for fungal and bacterial infections. Founded in 2012, the company’s goal is to change the way in which potent medicines are delivered and administered, with the aim of giving both physicians and patients better, […]

Before the opening bell, Monaker Group, Inc. (OTCQB: MKGI) announced the launch of a new travel service and loyalty program as part of its ongoing partnership with Recruiter.com, a leading global recruiting service and job market technology platform. According to the news release, the new travel program, which will be available to qualified Recruiter.com members […]

According to a past article on MarketWatch (http://dtn.fm/ruK1O), after the Fukushima nuclear disaster there was an increase in liquefied natural gas (LNG) demand in 2012. This meant that the LNG carrier fleet was operating at a 98% utilization rate. These numbers eventually decreased due to the delay of several liquefaction projects and slowing LNG demand […]